Insiders AstraZeneca PLC Nasdaq

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 17/06/2024 BST			Pre-market 12:24:48
79.31 ^USD	-0.35%		78.64	-0.85%

01:20pm	ASTRAZENECA : Goldman Sachs maintains a Buy rating	ZD
10:34am	AstraZeneca disappointed by breast cancer drug trial results	AN

Ipsen: new President for North America	05-02	CF
AstraZeneca shareholders approve 2024 pay policy in boost to CEO Soriot	04-11	RE
AstraZeneca shareholders approve 2024 pay policy at AGM	04-11	RE
AstraZeneca CEO Soriot on Pharmaceuticals in China	03-27	MT
Repeat & Correct : Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale -- Update	03-19	DJ
Pfizer to Raise Around $4.27 Billion From Haleon Shares Sale -- Update	03-19	DJ
AstraZeneca Announces Appointment of Manali Mukherjee as Chair in Respiratory Diseases	02-12	CI
AstraZeneca CEO Soriot: Entering the obesity market	02-08	MT
A new ETF dedicated to anti-obesity drugs (Ozempic, Mounjaro, Wegovy)!	11-27	MT
AstraZeneca Chair Demare buys shares for over GBP200,000	11-23	AN
Sutro Biopharma Promotes Jane Chung to Newly Created Position of COO	11-21	MT
Lancashire Holdings declares special dividend after strong year so far	11-09	AN
Lancashire Appoints AstraZeneca Director as Chair Designate	11-09	MT
Activist investor Elliott targets drugmaker BioMarin -sources	11-07	RE
Soriot commits to five more years as AstraZeneca CEO - Times	25/10/23	AN
AstraZeneca CEO Rejects Media Claims of Departure Plans	23/10/23	MT
Smith & Nephew brings BT Chief Financial Officer Simon Lowth to board	14/09/23	AN
AstraZeneca CEO Mulls Resignation in FY24	11/09/23	MT
INTERVIEW - Xuefeng Yu, CEO of CanSino Biologics: Behind the scenes of the agreement with AstraZeneca	31/08/23	MT
Catalent to settle with Elliott, explore options -sources	28/08/23	RE

No results for this search

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 05:02 pm